Menopause can worsen symptoms of bipolar disorder. In rare cases, it may trigger bipolar disorder. Menopause is a factor when ...
Titusville: Johnson & Johnson has announced the decision to discontinue the Phase 3 VENTURA development program evaluating ...
NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, presented two significant studies at the ...
MedPage Today on MSN2d
Chronic Pain Sufferers No Stranger to Depression and AnxietyAmong 347,468 individuals who had lived with persistent pain for over 3 months, clinical symptoms of depression and anxiety ...
Major depressive disorder with seasonal patterns, also known as seasonal affective disorder, causes symptoms similar to ...
Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion ...
Johnson & Johnson (JNJ) stock in focus as company halts Phase 3 depression therapy trials for aticaprant over efficacy ...
Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...
Johnson & Johnson has added to the opioid kappa blues. Months after Neumora reported a phase 3 flop, J&J has stopped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback